Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers (Q35566231)
Jump to navigation
Jump to search
scientific article published on 15 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers |
scientific article published on 15 February 2011 |
Statements
1 reference
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers (English)
1 reference
Justin M Balko
1 reference
Gordon B Mills
1 reference
Ritwik Ghosh
1 reference
Archana Narasanna
1 reference
Shizhen Emily Wang
1 reference
Shuying Liu
1 reference
Anindita Chakrabarty
1 reference
Ana María González-Angulo
1 reference
Elicia Penuel
1 reference
John Winslow
1 reference
Jeff Sperinde
1 reference
Rajiv Dua
1 reference
Sailaja Pidaparthi
1 reference
Ali Mukherjee
1 reference
Kim Leitzel
1 reference
Wolfgang J Kostler
1 reference
Allan Lipton
1 reference
Michael Bates
1 reference
Carlos L Arteaga
1 reference
15 February 2011
1 reference
1 reference
Identifiers
1 reference